Physician profile
Hakeem Ayinde
NPI 1366706111
$25,914.94
in general payments reported to CMS, 2019-2025
29 companies · $7,804 in 2025
The $7,804 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,003 · 2020: $1,928 · 2021: $292 · 2022: $3,421 · 2023: $5,561 · 2024: $3,906 · 2025: $7,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $5,970 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,400.52 |
| Travel and Lodging | $5,970.09 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $5,739.01 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Medtronic, INC. | $5,111.28 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Biotronik INC. | $3,986.15 | 2022-2023 | |
| Medtronic Vascular, INC. | $3,286.38 | 2019-2020 | |
| Atricure, INC. | $1,466.87 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $1,464.51 | 2019-2025 | Farapulse, Watchman Access System |
| Medical Device Business Services, INC. | $1,341.28 | 2023-2024 | Carto 3 |
| Abbott Laboratories | $1,333.54 | 2019-2025 | Ensite, Ensite Precision, Na |
| Bayer Healthcare Pharmaceuticals INC. | $366.86 | 2023-2024 | |
| Philips North America LLC | $299.09 | 2023-2024 | (5044) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.13 | 2020-2025 | Lifevest |
| Edwards Lifesciences Corporation | $239.24 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiva Medical, INC. | $158.15 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $140.94 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $130.73 | 2022-2024 | Xarelto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $109.08 | 2023 | Brilinta, Farxiga |
| Alnylam Pharmaceuticals INC. | $99.98 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $89.43 | 2021-2025 | Camzyos, Eliquis |
| Pfizer INC. | $83.29 | 2023-2025 | |
| Amgen INC. | $34.79 | 2021-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $32.99 | 2025 | |
| Cvrx, INC. | $26.63 | 2025 | Barostim Neo System |
| Penumbra, INC. | $24.76 | 2023 | Indigo System |
| Bridgebio Pharma, INC. | $22.74 | 2025 | Attruby |
| Heartflow, INC. | $22.16 | 2025 | |
| Sanofi-Aventis U.S. LLC | $14.85 | 2024 | |
| Impulse Dynamics (USA) INC. | $14.75 | 2024 | Optimizer |
| Merck Sharp & Dohme LLC | $13.82 | 2023 | Verquvo |
| Altathera Pharmaceuticals LLC | $11.51 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hakeem Ayinde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.